| Quantity: | |
|---|---|
FY-P33
The OEM Disposable Semaglutide Pen is a next-generation, single-use injection device designed for precision, safety, and full customization. Tailored for semaglutide and other GLP-1 peptide therapies, it integrates multi-patented internal technologies that ensure reliable dosing performance and compatibility across diverse formulations.
Highly Customizable OEM Design
Supports complete customization of dose scales, exterior color, logo placement, labeling, and packaging.
Enables pharmaceutical partners to create exclusive product identities aligned with brand and regional market needs.
Customizable injection volumes to meet different therapeutic regimens and patient requirements.
Multi-Patent Technical Innovation
Developed through independent R&D and protected by multiple proprietary patents, covering inner transmission systems, safety locks, and dosing mechanisms.
Provides partners with freedom to operate (FTO) and helps avoid potential patent conflicts with existing market products.
Broad Drug Compatibility
Designed to accommodate various peptide-based and biologic drugs, including semaglutide, liraglutide, tirzepatide, insulin, and similar formulations.
Constructed using non-reactive, medical-grade materials, ensuring drug stability and maintaining therapeutic integrity.
Accurate & Effortless Delivery
Precision-engineered mechanism ensures consistent dose accuracy, even across large-scale production batches.
Smooth, low-force injection improves patient comfort and compliance.
Safe & Convenient Single-Use Design
The disposable format ensures maximum sterility, reducing cross-contamination risk.
Ideal for clinical trials, commercial launches, and patient self-administration.
With its multi-patent protection, extensive drug compatibility, and fully customizable OEM design, the Disposable Semaglutide Pen delivers a versatile, safe, and brand-ready solution for pharmaceutical companies seeking reliable and scalable GLP-1 drug delivery systems.
The OEM Disposable Semaglutide Pen is a next-generation, single-use injection device designed for precision, safety, and full customization. Tailored for semaglutide and other GLP-1 peptide therapies, it integrates multi-patented internal technologies that ensure reliable dosing performance and compatibility across diverse formulations.
Highly Customizable OEM Design
Supports complete customization of dose scales, exterior color, logo placement, labeling, and packaging.
Enables pharmaceutical partners to create exclusive product identities aligned with brand and regional market needs.
Customizable injection volumes to meet different therapeutic regimens and patient requirements.
Multi-Patent Technical Innovation
Developed through independent R&D and protected by multiple proprietary patents, covering inner transmission systems, safety locks, and dosing mechanisms.
Provides partners with freedom to operate (FTO) and helps avoid potential patent conflicts with existing market products.
Broad Drug Compatibility
Designed to accommodate various peptide-based and biologic drugs, including semaglutide, liraglutide, tirzepatide, insulin, and similar formulations.
Constructed using non-reactive, medical-grade materials, ensuring drug stability and maintaining therapeutic integrity.
Accurate & Effortless Delivery
Precision-engineered mechanism ensures consistent dose accuracy, even across large-scale production batches.
Smooth, low-force injection improves patient comfort and compliance.
Safe & Convenient Single-Use Design
The disposable format ensures maximum sterility, reducing cross-contamination risk.
Ideal for clinical trials, commercial launches, and patient self-administration.
With its multi-patent protection, extensive drug compatibility, and fully customizable OEM design, the Disposable Semaglutide Pen delivers a versatile, safe, and brand-ready solution for pharmaceutical companies seeking reliable and scalable GLP-1 drug delivery systems.
